Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01177 SINO BIOPHARM
RT Nominal down3.200 -0.010 (-0.312%)
Latest  |  Final  |  Interim
Non-current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties281,564-2.688%289,342720,754705,626308,559
Property, plant, equip. & others8,036,893-0.545%8,080,9077,759,5927,154,2986,870,288
Land & other Lease Assets1,640,872-10.396%1,831,2541,491,5911,361,7641,521,916
Intangible Assets3,123,3597.370%2,908,9611,914,4501,711,9461,013,636
Interests in Asso. & JCEs11,835,188-3.336%12,243,67513,198,15714,266,3965,050,637
Other Non-current Assets16,563,86914.667%14,445,14913,044,83511,840,1299,651,199

41,481,7454.227%39,799,28838,129,37937,040,15924,416,235
Current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories1,837,297-7.834%1,993,4722,328,8441,937,7411,880,051
Trade Receivables7,215,53759.983%4,510,1954,638,3964,220,6672,914,077
Cash & Bank Balances8,549,473-9.547%9,451,87812,066,21710,568,81211,259,084
Other Current Assets7,619,6899.837%6,937,2806,901,4486,775,9586,740,991
Assets Held for Sale0--912,706000

25,221,9965.950%23,805,53125,934,90523,503,17822,794,203
Current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables2,183,40663.587%1,334,7031,637,3511,693,1521,947,802
S-T Debt & Leases8,511,892-24.051%11,207,4289,723,8416,585,0381,581,524
Other Current Liabilities11,253,91414.535%9,825,7858,789,4857,066,8297,414,213
Liab asso w/ Assets Held for Sale0--238,859000

21,949,212-2.909%22,606,77520,150,67715,345,01910,943,539
Net Current Assets3,272,784173.015%1,198,7565,784,2288,158,15911,850,664
Total Assets Less Current Liabilities44,754,5299.163%40,998,04443,913,60745,198,31836,266,899
Non-current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases1,164,669-15.162%1,372,8164,258,1225,532,47512,628,300
Other Non-current Liabilities1,468,1780.887%1,455,2751,711,9371,936,8201,219,041

2,632,847-6.904%2,828,0915,970,0597,469,29513,847,341
Capital and Reserves
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital414,384-0.056%414,615414,899415,440415,895
  Reserves32,430,6007.887%30,059,85429,332,13629,875,67616,331,265
  Others0--0000
Shareholders' Funds32,844,9847.779%30,474,46929,747,03530,291,11616,747,160
Non-controlling Interests9,276,69820.547%7,695,4848,196,5137,437,9075,672,398
Others0--0000

42,121,68210.353%38,169,95337,943,54837,729,02322,419,558
Commitments and Contingent Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----535,5461,811,239950,0381,224,839
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 23/12/2024 09:17
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 3,017,162
%Change139.689%
EPS / (LPS)RMB 0.164
NBV Per Share (¥)RMB 1.748
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.